Seer, Inc. (SEER) — 10-Q Filings
All 10-Q filings from Seer, Inc.. Browse 6 Quarterly Report reports with AI-powered summaries and risk analysis.
10-Q Filings (6)
-
Seer Narrows Losses, Boosts Service Revenue Amid Global Push
— Nov 6, 2025 Risk: medium
Seer, Inc. reported a net loss of $18.2 million for the three months ended September 30, 2025, an improvement from a net loss of $21.3 million in the same perio -
Seer's Q2 Loss Widens to $25.3M Amid Rising R&D, Sales Up 14.6%
— Aug 6, 2025 Risk: high
Seer, Inc. reported a net loss of $25.3 million for the three months ended June 30, 2025, a significant increase from the $20.1 million net loss in the prior-ye -
Seer, Inc. Files Q1 2025 10-Q
— May 13, 2025 Risk: low
Seer, Inc. filed its 10-Q for the period ending March 31, 2025. The company, formerly Seer Biosciences, Inc., is in the business of laboratory analytical instru -
Seer, Inc. Q3 2024 Update: Revenue, R&D, and Strategic Deals
— Nov 6, 2024 Risk: medium
Seer, Inc. filed its 10-Q for the period ending September 30, 2024. The company reported sales revenue and research and development expenses for the third quart -
Seer, Inc. Files Q2 2024 10-Q with Financial Updates
— Aug 8, 2024 Risk: medium
Seer, Inc. filed its 10-Q for the period ending June 30, 2024. The company reported on its financial position and operations, including details on research and -
Seer, Inc. Files 10-Q for Period Ending March 31, 2024
— May 8, 2024 Risk: medium
Seer, Inc. (SEER) filed a Quarterly Report (10-Q) with the SEC on May 8, 2024. Seer, Inc. filed its 10-Q report for the period ending March 31, 2024. The filing
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX